2018 Q4 Form 10-K Financial Statement

#000119312520090214 Filed on March 30, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $804.2K $886.3K $1.073M
YoY Change 7377.03% 82.79%
Cost Of Revenue
YoY Change
Gross Profit $804.2K $886.3K $1.073M
YoY Change 7377.03% 82.79%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $2.500M $1.360M $1.489M
YoY Change 62.34% -27.02% -14.88%
% of Gross Profit 310.86% 153.43% 138.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $70.00K $100.0K $130.0K
YoY Change -56.25% -41.18% -38.1%
% of Gross Profit 8.7% 11.28% 12.11%
Operating Expenses $2.500M $1.360M $1.489M
YoY Change 62.34% -27.02% -14.88%
Operating Profit -$1.696M -$1.544M -$868.6K
YoY Change 10.12% -37.47% -57.9%
Interest Expense -$830.0K $816.7K $730.9K
YoY Change 16.9% 27.83% 9.96%
% of Operating Profit
Other Income/Expense, Net -$10.00K -$778.5K -$741.4K
YoY Change 22.45% 15.23%
Pretax Income -$2.530M -$2.323M -$1.610M
YoY Change 12.44% -25.2% -40.51%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.477M -$1.309M -$641.6K
YoY Change 6.08% -41.84% -66.53%
Net Earnings / Revenue -183.64% -147.72% -59.76%
Basic Earnings Per Share -$0.15 -$0.08
Diluted Earnings Per Share -$165.7K -$0.15 -$0.08
COMMON SHARES
Basic Shares Outstanding 8.467M shares 8.467M 8.467M
Diluted Shares Outstanding 8.467M 8.467M

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.790M $130.0K $570.0K
YoY Change 151.35% -90.3% -61.49%
Cash & Equivalents $2.787M $130.4K $565.8K
Short-Term Investments
Other Short-Term Assets $1.016M $286.2K $283.4K
YoY Change 105.06% 18.23% 26.26%
Inventory
Prepaid Expenses $478.6K
Receivables $789.4K $667.2K $741.6K
Other Receivables $120.0K $50.00K
Total Short-Term Assets $4.603M $1.094M $1.601M
YoY Change 149.31% -41.13% -19.82%
LONG-TERM ASSETS
Property, Plant & Equipment $118.0K $195.5K $295.6K
YoY Change -80.13% -73.93% -67.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $750.0K $530.0K
YoY Change
Other Assets $0.00 $532.5K $532.5K
YoY Change -100.0% 0.0% 0.0%
Total Long-Term Assets $870.6K $1.258M $1.134M
YoY Change -22.7% -1.91% -22.09%
TOTAL ASSETS
Total Short-Term Assets $4.603M $1.094M $1.601M
Total Long-Term Assets $870.6K $1.258M $1.134M
Total Assets $5.473M $2.352M $2.735M
YoY Change 84.13% -25.11% -20.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.772M $3.001M $2.678M
YoY Change 15.67% 42.03% 80.41%
Accrued Expenses $9.805M $8.760M $8.070M
YoY Change 49.66% 44.32% 41.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $29.45M $25.89M $25.87M
YoY Change 20.89% 11.84% 19.71%
Total Short-Term Liabilities $42.03M $37.65M $36.62M
YoY Change 26.16% 20.19% 27.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $3.500M $3.500M
YoY Change -100.0% 16.67% 16.67%
Other Long-Term Liabilities $4.640M $4.640M $4.640M
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Liabilities $4.644M $8.144M $8.144M
YoY Change -39.25% 6.54% 6.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.03M $37.65M $36.62M
Total Long-Term Liabilities $4.644M $8.144M $8.144M
Total Liabilities $46.67M $45.80M $44.76M
YoY Change 13.95% 17.51% 22.8%
SHAREHOLDERS EQUITY
Retained Earnings -$239.9M -$238.4M -$237.1M
YoY Change 2.2% 2.18% 2.61%
Common Stock $218.0M $213.2M $212.3M
YoY Change 2.78% 0.57% 0.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$21.89M -$25.19M -$24.78M
YoY Change
Total Liabilities & Shareholders Equity $5.473M $2.352M $2.735M
YoY Change 84.13% -25.11% -20.78%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$1.477M -$1.309M -$641.6K
YoY Change 6.08% -41.84% -66.53%
Depreciation, Depletion And Amortization $70.00K $100.0K $130.0K
YoY Change -56.25% -41.18% -38.1%
Cash From Operating Activities -$2.080M -$1.160M -$1.200M
YoY Change 58.78% -26.58% -31.03%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.740M 730.0K 400.0K
YoY Change 338.89% -48.59% -80.95%
NET CHANGE
Cash From Operating Activities -2.080M -1.160M -1.200M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 4.740M 730.0K 400.0K
Net Change In Cash 2.660M -430.0K -800.0K
YoY Change -1256.52% 230.77% -295.12%
FREE CASH FLOW
Cash From Operating Activities -$2.080M -$1.160M -$1.200M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$2.080M -$1.160M -$1.200M
YoY Change 58.78% -26.58% -31.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Assets
Assets
5329720
CY2018Q4 us-gaap Assets
Assets
5473170
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
203254
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2786832
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10135
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1224822
CY2018Q4 us-gaap Assets Current
AssetsCurrent
4602524
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1500000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
13419680
CY2018Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
752667
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26806
CY2019Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
3348057
CY2018Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
752667
CY2019Q4 us-gaap Liabilities
Liabilities
58627136
CY2018Q4 us-gaap Liabilities
Liabilities
46669707
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5329720
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5473170
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6237987
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2772423
CY2019Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
13422715
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
9804546
CY2019Q4 us-gaap Loans Payable Current
LoansPayableCurrent
31446389
CY2018Q4 us-gaap Loans Payable Current
LoansPayableCurrent
29448988
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
51230243
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
42025957
CY2019Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
2957097
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7396893
CY2018Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4643750
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10664948
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11033536
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10647910
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10915557
CY2019Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2018Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
948
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
922
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
221027057
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
217993953
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-250322307
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239882346
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-29294302
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-21887471
CY2019Q4 us-gaap Minority Interest
MinorityInterest
-24003114
CY2018Q4 us-gaap Minority Interest
MinorityInterest
-19309066
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-53297416
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-41196537
CY2019 us-gaap Interest Expense
InterestExpense
5360192
CY2018 us-gaap Interest Expense
InterestExpense
3142280
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.12
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.95
CY2017 us-gaap Interest Expense
InterestExpense
2727235
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
819517
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48803
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3072987
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3275753
CY2019 omex Operations And Research Expense
OperationsAndResearchExpense
7927831
CY2018 omex Operations And Research Expense
OperationsAndResearchExpense
3688560
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
9342969
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5153033
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3037069
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1248477
CY2017 omex Operations And Research Expense
OperationsAndResearchExpense
3438389
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
9605570
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
63074
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2664049
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5059765
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3931849
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3261670
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15499726
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9104285
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11021142
CY2019 us-gaap Depreciation
Depreciation
116434
CY2018 us-gaap Depreciation
Depreciation
453466
CY2019 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
845892
CY2018 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
111180
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
55200
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
278947
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-367828
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
578156
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-355126
CY2018 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-11891
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3690481
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
496068
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3960783
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3528805
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15492
CY2018 omex Settlement Receipts From Contractual Obligations
SettlementReceiptsFromContractualObligations
15000000
CY2018 omex Payment Of Contractual Obligations
PaymentOfContractualObligations
14000000
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
346130
CY2018 us-gaap Repayments Of Debt
RepaymentsOfDebt
349598
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2876213
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7137016
CY2019 omex Director Fees Settled With Equity Instruments
DirectorFeesSettledWithEquityInstruments
701396
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
897664
CY2018 omex Payments For Proceeds From Restricted Cash Held As Collateral
PaymentsForProceedsFromRestrictedCashHeldAsCollateral
125
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5444299
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6452415
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9624
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15492
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
994038
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2583578
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1678639
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1544663
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1247337
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10135
CY2019 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
4.93
CY2018 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
6.81
CY2017 us-gaap Accelerated Share Repurchases Final Price Paid Per Share
AcceleratedShareRepurchasesFinalPricePaidPerShare
3.98
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1112293
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
981783
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-290024
CY2019Q4 omex Property Plant And Equipment Subject To Operating Leases
PropertyPlantAndEquipmentSubjectToOperatingLeases
739803
CY2019 omex Debt Modification Inducement
DebtModificationInducement
-868878
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
225324
CY2019 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-10439961
CY2018 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-5172436
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9346213
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8583795
CY2017 omex Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-7759472
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8209539
CY2019Q4 us-gaap Loans Payable
LoansPayable
34403486
CY2018Q4 us-gaap Loans Payable
LoansPayable
29448988
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
123152
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
621046
CY2019 omex Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
53233
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-290024
CY2019 omex Payment Of Operating Lease Liability
PaymentOfOperatingLeaseLiability
48838
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56819522
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52684059
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4135463
CY2019Q4 omex Working Capital Deficit
WorkingCapitalDeficit
50000000
CY2019Q4 omex Percentage Of Annual Rent Accretion In Operating Lease
PercentageOfAnnualRentAccretionInOperatingLease
0.03
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
67425
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
550609
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
546964
CY2019Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
290024
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
129487
CY2019Q4 omex Fair Value Reacquisition Price
FairValueReacquisitionPrice
1340024
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3818750
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4643750
CY2019Q4 omex Revenue Participation Agreement Value
RevenueParticipationAgreementValue
15000000
CY2019Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
700000
CY2019Q4 us-gaap Accounts Payable Interest Bearing Interest Rate
AccountsPayableInterestBearingInterestRate
0.12
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9478009
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9222199
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
24984166
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9478009
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9222199
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5491849
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5654409
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6167181
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-10346693
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-6067216
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-8357093
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
151
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
56408
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
112
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-322485
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9346213
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8583795
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8209539
CY2019 us-gaap Profit Loss
ProfitLoss
-15499726
CY2018 us-gaap Profit Loss
ProfitLoss
-9104285
CY2017 us-gaap Profit Loss
ProfitLoss
-11021142
CY2017 omex Senior Convertible Debit Interest Settled With Common Stock Issuance
SeniorConvertibleDebitInterestSettledWithCommonStockIssuance
302274
CY2017 us-gaap Depreciation
Depreciation
760766
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-322485
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
747333
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
752667
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
725875
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
289328
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-241426
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-113922
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
999488
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1881977
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5850682
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
80000
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3271181
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1925000
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5625000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4561739
CY2017 us-gaap Repayments Of Debt
RepaymentsOfDebt
408768
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5216232
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-554450
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2786832
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1108193
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1662643
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
203254
CY2017 us-gaap Interest Paid Net
InterestPaidNet
622055
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
793036
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
793036
CY2019Q4 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
224916
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1003662
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
80000
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000798528
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Trading Symbol
TradingSymbol
OMEX
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9478009
CY2019Q2 dei Entity Public Float
EntityPublicFloat
49400000
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019Q4 omex Property Plant And Equipment Gross Including Right Of Use Asset
PropertyPlantAndEquipmentGrossIncludingRightOfUseAsset
11404751
CY2018Q4 omex Property Plant And Equipment Gross Including Right Of Use Asset
PropertyPlantAndEquipmentGrossIncludingRightOfUseAsset
11033536
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
756841
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
117979
CY2018Q4 us-gaap Capitalized Costs Asset Retirement Costs
CapitalizedCostsAssetRetirementCosts
4600000
CY2018 omex Vessel Assets Sold And Consideration Received In Kind
VesselAssetsSoldAndConsiderationReceivedInKind
100000
CY2018 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
1000000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
584765
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
478560
CY2018Q4 us-gaap Security Deposit
SecurityDeposit
532500
CY2019Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
5075
CY2018Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
5076
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
589840
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1016136
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
421593
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
789421
CY2019Q4 omex Collateral Asset Carrying Value
CollateralAssetCarryingValue
0
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
794927
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
774436
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
762175
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
741449
CY2019Q1 us-gaap Gross Profit
GrossProfit
794927
CY2019Q2 us-gaap Gross Profit
GrossProfit
774436
CY2019Q3 us-gaap Gross Profit
GrossProfit
762175
CY2019Q4 us-gaap Gross Profit
GrossProfit
741449
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1167886
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-2774282
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-4229833
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-2267960
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
511735
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1073479
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
886327
CY2018Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
804212
CY2018Q1 us-gaap Gross Profit
GrossProfit
511735
CY2018Q2 us-gaap Gross Profit
GrossProfit
1073479
CY2018Q3 us-gaap Gross Profit
GrossProfit
886327
CY2018Q4 us-gaap Gross Profit
GrossProfit
804212
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1744762
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-641557
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1309275
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-1476842
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2018 omex Payment For One Time Revenue Distribution
PaymentForOneTimeRevenueDistribution
12986
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
170631
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
170631
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3254942
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1923757
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3718058
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-156858
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-92707
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-110667
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
262776
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
29670
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
711679
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5170161
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3765560
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
28258724
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-2021137
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1778766
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-1097681
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-24043997
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
590612
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2821349
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2567732
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
422130
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
400367
CY2019Q4 omex Earnest Money Deposit
EarnestMoneyDeposit
-450000
CY2019Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
9494391
CY2018Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
6508621
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
221504
CY2018Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
309826
CY2019Q4 omex Accrued Other Operating Expenses Current
AccruedOtherOperatingExpensesCurrent
13341
CY2018Q4 omex Accrued Other Operating Expenses Current
AccruedOtherOperatingExpensesCurrent
18000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13422715
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9804546
CY2018Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
2600000
CY2019Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
200000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
825000
CY2019Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
16000
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2600000
CY2019 omex Number Of Financial Institutions In Which Cash Deposited
NumberOfFinancialInstitutionsInWhichCashDeposited
1
CY2019Q4 us-gaap Loans Receivable With Variable Rates Of Interest1
LoansReceivableWithVariableRatesOfInterest1
0
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 13%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management uses estimates and assumptions in preparing these consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were used. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q4 omex Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards
52876144
CY2019Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
5052
CY2019Q4 omex Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpenses
614467
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
238651
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P4Y10M2D
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
15.95
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1016135
CY2019 dei Entity Registrant Name
EntityRegistrantName
ODYSSEY MARINE EXPLORATION INC
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 omex Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accounts Receivable
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsReceivable
156538
CY2019Q4 omex Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
2595
CY2019Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
604287
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1343100
CY2019Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
1387970
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56819522
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
43155
CY2019Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
127476
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-10439961
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-5172436
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-7759472
CY2019 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2018 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2017 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
0
CY2019 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
9346213
CY2018 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
8583795
CY2017 omex Shares Used In Computation For Earning Per Share Basic
SharesUsedInComputationForEarningPerShareBasic
8209539
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2019 dei Security12b Title
Security12bTitle
Common Stock
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
869783
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
8299
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
861484
CY2019 omex Short Term Investments Maturity Period
ShortTermInvestmentsMaturityPeriod
P3M
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019Q4 omex Redeemable Preferred Stock Outstanding
RedeemablePreferredStockOutstanding
0
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15564
CY2018Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15564
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15564
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15564
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
0
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
231952
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
828497
CY2019Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
0
CY2018Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
0
CY2017Q4 omex Share Based Compensation Awards Options Estimated Weighted Average Grant Date Fair Value
ShareBasedCompensationAwardsOptionsEstimatedWeightedAverageGrantDateFairValue
0
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2019 us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
0
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
825000
CY2019 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
92884
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
384060
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
692153
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-37982936
CY2018 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
756596
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
415615
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
833985
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2015-08-31
CY2019 omex Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
3
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
143241
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
147539
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
151965
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
156524
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
332415
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84598
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
247817
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9166
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
238651
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
238651
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.55
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
35.59
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.76
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
36.52
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.95
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.95
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
247817
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
238651
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
238651
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.76
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.95
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.95
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
50000
CY2018Q4 omex Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards
48404432
CY2018Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
147552
CY2018Q4 omex Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedExpenses
559096
CY2018Q4 omex Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accounts Receivable
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsReceivable
287335
CY2018Q4 omex Deferred Tax Assets Start Up Costs
DeferredTaxAssetsStartUpCosts
7042
CY2018Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
707044
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1331067
CY2018Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
1387970
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
52684059
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
147479
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
43155
CY2018Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
104324
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
147479
CY2018 us-gaap Professional Fees
ProfessionalFees
230500
CY2019 omex Additional Professional Fees
AdditionalProfessionalFees
80509
CY2019Q4 omex Exploration License
ExplorationLicense
1821251
CY2019 us-gaap Debt Conversion Description
DebtConversionDescription
Applicable Conversion Amount&#8221; means, on the date of determination and with respect to each Note, (a) for the period beginning on the date of issuance and ending on the day immediately preceding the Maturity Date, an amount equal to 100.0% of the amount of the Loan evidenced by such Note then outstanding; (b) on the Maturity Date, 136.0% of the amount of the Loan evidenced by such Note then outstanding (such amount, the &#8220;Enhanced Conversion Amount&#8221;); (c) for the period beginning on the day immediately following the Maturity Date and for a period of three months thereafter (such three-month period, the &#8220;Accrual Period&#8221;), an amount equal to (i) the Enhanced Conversion Amount then outstanding plus (ii) an additional amount equal to 3.0% per month (prorated for any period of less than a full month) accrued on the amount described in clause (i); and (d) on any date after the Accrual Period, the amount then outstanding after giving effect to the accrual described in clause (c) during the Accrual Period (it being understood that no additional amount shall accrue after the expiration of the Accrual Period); and &#8220;Applicable Conversion Rate&#8221; means (x) with respect to any conversion on or prior to the Maturity Date, $5.00, and (y) with respect to any conversion after the Maturity Date, the lower of (i) $5.00 and (ii) 80.0% of the ten-day volume-weighted average price of Odyssey&#8217;s common stock. Notwithstanding anything in the Purchase Agreement to the contrary, we are prohibited from issuing any Conversion Shares, to the extent such shares, after giving effect to such issuance after conversion and when added to the number of Conversion Shares previously issued upon conversion of any of the Notes sold pursuant to the Purchase Agreement, would represent in excess of 19.9% of (A) the number of shares of our common stock outstanding immediately after giving effect to such issuances or (B) the total voting power of our securities outstanding immediately after giving effect to such issuances that are entitled to vote on a matter being voted on by holders of our common stock.
CY2017 omex Number Of Outside Directors Granted Quarterly Fees
NumberOfOutsideDirectorsGrantedQuarterlyFees
0
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0

Files In Submission

Name View Source Status
0001193125-20-090214-index-headers.html Edgar Link pending
0001193125-20-090214-index.html Edgar Link pending
0001193125-20-090214.txt Edgar Link pending
0001193125-20-090214-xbrl.zip Edgar Link pending
d884274d10k.htm Edgar Link pending
d884274dex1037.htm Edgar Link pending
d884274dex1038.htm Edgar Link pending
d884274dex1039.htm Edgar Link pending
d884274dex1040.htm Edgar Link pending
d884274dex211.htm Edgar Link pending
d884274dex231.htm Edgar Link pending
d884274dex232.htm Edgar Link pending
d884274dex311.htm Edgar Link pending
d884274dex312.htm Edgar Link pending
d884274dex321.htm Edgar Link pending
d884274dex322.htm Edgar Link pending
d884274dex42.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g884274dsp102.jpg Edgar Link pending
g884274dsp102a.jpg Edgar Link pending
g884274dsp102c.jpg Edgar Link pending
g884274dsp102d.jpg Edgar Link pending
g884274dsp102e.jpg Edgar Link pending
g884274g02a62.jpg Edgar Link pending
g884274g0312070919519.jpg Edgar Link pending
g884274g0312074712423.jpg Edgar Link pending
g884274g0312075421907.jpg Edgar Link pending
g884274g0312075422156.jpg Edgar Link pending
g884274g65g23.jpg Edgar Link pending
g884274g81c06.jpg Edgar Link pending
g884274img1.jpg Edgar Link pending
omex-20191231.xml Edgar Link completed
omex-20191231.xsd Edgar Link pending
omex-20191231_cal.xml Edgar Link unprocessable
omex-20191231_def.xml Edgar Link unprocessable
omex-20191231_lab.xml Edgar Link unprocessable
omex-20191231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending